Rapid and efficient cell labeling with a MRI contrast agent by electroporation in the presence of protamine sulfate

Nanomedicine

Volumn 4, Issue 3, 2009, Pages 305-315

  Wang, Lijun ^a   Wang, Zhigang ^a   Frank, Tim G ^a   Brown, Stuart I ^a   Chudek, Sandy A ^a   Cuschieri, Alfred ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Electroporation; Magnetic cell labeling; MRI; Protamine sulfate; SPION; Transfection

Indexed keywords

IRON; POLYLYSINE; PROTAMINE SULFATE; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; OXIDE; PROTAMINE;

ARTICLE; CANCER CELL; CELL CULTURE; CELL LABELING; CELL METABOLISM; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ELECTROPORATION; HUMAN; HUMAN CELL; IMAGE ENHANCEMENT; IN VITRO STUDY; INTERNALIZATION; IRON TRANSPORT; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PRIORITY JOURNAL; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; METABOLISM; METHODOLOGY; STAINING; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTRAST MEDIA; ELECTROPORATION; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; OXIDES; POLYLYSINE; PROTAMINES; REACTIVE OXYGEN SPECIES; STAINING AND LABELING;

EID: 66149156992     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.09.6     Document Type: Article

References (34)

1. Lewin M, Carlesso N, Tung CH et al.: Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol.18 (4),410-414 (2000).
2. Bulte JW, Douglas T, Witwer B et al.: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol.19(12),1141-1147 (2001).
3. Frank JA, Anderson SA, Kalsih H et al.: Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy6(6),621-625 (2004).
4. Rogers WJ, Meyer CH, Kramer CM: Technology insight: in vivo cell tracking by use of MRI. Nat. Clin. Pract. Cardiovasc. Med.3(10),554-562 (2006).
5. Gehl J: Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand.177 (4),437-447 (2003).
6. Walczak P, Ruiz-Cabello J, Kedziorek DA et al.: Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine2(2),89-94 (2006).
7. Suzuki Y, Zhang S, Kundu P, Yeung AC, Robbins RC, Yang PC: In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Magn. Reson. Med.57 (6),1173-1179 (2007).
8. Arbab AS, Bashaw LA, Miller BR et al.: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology229(3),838-846 (2003).
9. Matuszewski L, Persigehl T, Wall A et al.: Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology235 (1),155-161 (2005).
10. Arbab AS, Yocum GT, Wilson LB et al.: Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol. Imaging3(1),24-32 (2004).
11. Azzam T, Domb AJ: Current developments in gene transfection agents. Curr. Drug. Deliv.1 (2),165-193 (2004).
12. Bull BS, Huse WM, Brauer FS, Korpman RA: Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J. Thorac. Cardiovasc. Surg.69(5),685-689 (1975).
13. Sorgi FL, Bhattacharya S, Huang L: Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther.4(9),961-968 (1997).
14. Arbab AS, Yocum GT, Kalish H et al.: Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood104(4),1217-1223 (2004).
15. Semelka RC, Helmberger TK: Contrast agents for MR imaging of the liver. Radiology218(1),27-38 (2001).
16. 1-weighted MR imaging. Radiology203 (2),449-456 (1997).
17. Skotland T, Sontum PC, Oulie I: In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. J. Pharm. Biomed. Anal.28(2),323-329 (2002).
18. Emerit J, Beaumont C, Trivin F: Iron metabolism, free radicals, and oxidative injury. Biomed. Pharmacother.55(6),333-339 (2001).
19. Tai JH, Foster P, Rosales A et al.: Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes55(11),2931-2938 (2006).
20. Neumann E, Toensing K, Kakorin S, Budde P, Frey J: Mechanism of electroporative dye uptake by mouse B cells. Biophys. J.74(1),98-108 (1998).
21. Rols MP, Teissié J: Electropermeabilization of mammalian cells to macromolecules: control by pulse duration. Biophys. J.75(3),1415-1423 (1998).
22. Puc M, Kotnik T, Mir LM, Miklavcic D: Quantitative model of small molecules uptake after in vitro cell electropermeabilization. Bioelectrochemistry60(12),1-10 (2003).
23. Saulis G: The loading of human erythrocytes with small molecules by electroporation. Cell. Mol. Biol. Lett.10(1),23-35 (2005).
24. Lee RC, River LP, Pan FS, Ji L, Wollmann RL: Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc. Natl Acad. Sci. USA.89(10),4524-4528 (1992).
25. Maskarinec SA, Hannig J, Lee RC, Lee KY: Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys. J.82 (3),1453-1459 (2002).
26. Sánchez L, Martínez V, Infante MR, Mitjans M, Vinardell MP: Hemolysis and antihemolysis induced by amino acid-based surfactants. Toxicol. Lett.169 (2),177-184 (2007).
27. Brannon-Peppas L, Blanchette JO: Nanoparticle and targeted systems for cancer therapy. Adv. Drug. Deliv. Rev.56(11),1649-1659 (2004).
28. McCarthy JR, Kelly KA, Sun EY, Weissleder R: Targeted delivery of multifunctional magnetic nanoparticles. Nanomed.2 (2),153-167 (2007).
29. Towner RA, Smith N, Tesiram YA et al.: In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging. Mol. Imaging6 (1),18-29 (2007).
30. Toma A, Otsuji E, Kuriu Y et al.: Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma. Br. J. Cancer93 (1),131-136 (2005).
31. Shan L, Wang S, Sridhar R, Bhujwalla ZM, Wang PC: Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts. Mol. Imaging6(2),85-95 (2007).
32. Moore A, Josephson L, Bhorade RM, Basilion JP, Weissleder R: Human transferrin receptor gene as a marker gene for MR imaging. Radiology221 (1),244-250 (2001).
33. Canatella PJ, Black MM, Bonnichsen DM, McKenna C, Prausnitz MR: Tissue electroporation: quantification and analysis of heterogeneous transport in multicellular environments. Biophys. J.86(5),3260-3268 (2004).
34. Terreno E, Crich SG, Belfiore S et al.: Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn. Reson. Med.55(3),491-497 (2006).